NASDAQ:KROS | Operating Income | Keros Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$30.94M
2026-03-31-$25.88M
2025-12-31-$29.27M
2025-09-30-$15.38M
2025-06-30-$39.82M
2025-03-31$152.04M
2024-12-31-$53.25M
2024-09-30-$58.66M
2024-06-30-$50.44M
2024-03-31-$48.48M
2023-12-31-$46.46M
2023-09-30-$43.28M
2023-06-30-$41.34M
2023-03-31-$38.87M
2022-12-31-$31.96M
2022-09-30-$27.98M
2022-06-30-$30.73M
2022-03-31-$24.13M
2021-12-31-$4.87M
2021-09-30-$20.2M
2021-06-30-$15.54M
2021-03-31-$15.77M
2020-12-31-$13.29M
2020-09-30-$11.95M
2020-06-30-$10.91M
2020-03-31-$10.5M
2019-12-31-$2.73M
2019-09-30-$2.33M
2019-06-30-$2.65M
2019-03-31-$2.86M

Annual Operating Income

DateOperating Income
2025-12-31$67.57M
2024-12-31-$210.83M
2023-12-31-$169.94M
2022-12-31-$114.79M
2021-12-31-$56.37M
2020-12-31-$46.66M
2019-12-31-$10.56M